|
|
|
|
 |
|
| Nutra Pharma is developing an innovative
pipeline of biopharmaceutical products |
|
|
|
|
|
|
|
|
|
|
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
|
|
|
Please select a year from the tabs below to begin
viewing archived Nutra Pharma press releases.
2007
December 27, 2007
Nutra Pharma Expands Licensing Agreement to Include Environmental Testing for NonTuberculous Mycobacterium
December 17, 2007
Nutra Pharma Announces Successful Completion of 6-Month Patient Crossover in AMN Clinical Trial
November 28, 2007
Nutra Pharma Posts ReceptoPharm Peer-Reviewed Article to Its Website
November 19, 2007
Nutra Pharma Announces Publication of Test Kit Technology in the International Journal of TB and Lung Diseases
November 8, 2007
Nutra Pharma Announces Designer Diagnostics Test Kit Technology to Be Presented at International Lung Health Conference
August 13, 2007
Shareholder Letter from Chairman and CEO Rik J. Deitsch
August 8, 2007
Nutra Pharma Announces Positive Results of ReceptoPharm Pain Study
July 10, 2007
Nutra Pharma Announces Successful Enrollment in ReceptoPharm Adrenomyeloneuropathy (AMN) Study
May 31, 2007
Nutra Pharma Announces Breakthrough with Rapid Tuberculosis Test Kit Technology
May 2, 2007
Nutra Pharma Announces Designer Diagnostics’ Clinical Trials to Be Conducted at National Jewish Medical and Research Center
April 17, 2007
Nutra Pharma Announces Successful Completion of Joint Venture Meetings in China
April 11, 2007
Nutra Pharma Announces ReceptoPharm Patent for a Method of Treating Multiple Sclerosis
March 27, 2007
Nutra Pharma Completes First Royalty Payment to NanoLogix for Test Kit Technology
March 26, 2007
Nutra Pharma Sponsors Educational Website about Tuberculosis (TB) in Conjunction with World TB Day
March 22, 2007
Nutra Pharma Announces Publication of Research on Treatment for Multiple Sclerosis
March 7, 2007
Nutra Pharma Announces ReceptoPharm’s Joint Venture with Chinese Biotechnology Company
March 1, 2007
Designer Diagnostics Engages U.S. Commercial Service for International Growth
February 28, 2007
Nutra Pharma Announces Partnership with World Aids Campaign
February 22, 2007
The Wall Street Transcript Interviews Nutra Pharma Chairman and CEO
February 14, 2007
Nutra Pharma Announces Shareholder Conference Call Scheduled for Wednesday, February 14, 2007
February 12, 2007
Nutra Pharma Chairman and CEO Outlines Business Strategy and Goals on CEOCast.com Interview
February 9, 2007
Nutra Pharma Announces Shareholder Conference Call to Discuss Recent News and Progress
February 8, 2007
National Television Series, Business & Beyond, to Feature Nutra Pharma on CNBC
February 2, 2007
ReceptoPharm Expands Antiviral Clinical Research to South America
January 29, 2007
ReceptoPharm Begins Phase IIb Human Clinical Trial for the Treatment of Adrenomyeloneuropathy
January 22, 2007
Shareholder Letter from Chairman and CEO Rik J. Deitsch
January 18, 2007
Designer Diagnostics Announces Positive Results from In-Vitro Analysis
January 16, 2007
Nutra Pharma Sponsors Educational Website for Adrenomyeloneuropathy (AMN)
January 11, 2007
Nutra Pharma Announces Breakthrough Research in the Treatment of Viral Infections
January 5, 2007
Nationally Distributed Magazine Publishes Article by Nutra Pharma Chairman and CEO Rik J Deitsch
|
2006
November 28, 2006
Nutra Pharma Announces ReceptoPharm to Present at the International Conference on Neurotoxins
November 21, 2006
Shareholder Letter from Chairman and CEO Rik J. Deitsch
November 3, 2006
Nutra Pharma Featured on Fox 2 News in St. Louis
October 31, 2006
Nutra Pharma Adopts Famous 2-Headed Snake of St. Louis’ World Aquarium
October 5, 2006
Nutra Pharma Announces Final Approval to Begin Phase IIb Human Clinical Trial for the Treatment of Adrenomyeloneuropathy
September 21, 2006
Nutra Pharma Announces ReceptoPharm to Be a Featured Speaker at the 11th Annual Immunobiology Symposium
August 31, 2006
Shareholder Letter from Chairman and CEO Rik J. Deitsch
August 29, 2006
Nutra Pharma Announces Former GlaxoSmithKline Global Clinical Development Director Joins ReceptoPharm Scientific Advisory Board
August 21, 2006
Nutra Pharma Announces Publication of Positive Results of ReceptoPharm Pain Study
July 14, 2006
Business 2.0 Publishes Article about Nutra Pharma Corporation
July 13, 2006
WallSt.Net Publishes Interview with Nutra Pharma CEO Rik J. Deitsch
June 19, 2006
ReceptoPharm Signs Letter of Intent to Be Acquired by Nutra Pharma Corporation
May 31, 2006
Shareholder Letter from Chairman and President Rik J. Deitsch
May 9, 2006
Nutra Pharma Announces Approval to Start Late Phase II Human Trials in England
May 4, 2006
Nutra Pharma Sponsors Educational Website for NonTuberculosis Mycobacterium (NTM)
May 3, 2006
The JALMA Institute Signs Purchase Agreement for Nutra Pharma's NTM Test Kits
April 19, 2006
Health on the Net Foundation Accredits Nutra Pharma Website
April 11, 2006
Nutra Pharma CEO Outlines Corporate Strategy on MacReport.Net
April 5, 2006
Nutra Pharma Launches Diagnostic Test Kits for the Rapid Identification of NonTuberculosis Mycobacterium
March 31, 2006
Nutra Pharma Announces Svizera Labs to Supply Designer Diagnostics' Test Kits to the World Health Organization
March 21, 2006
Nutra Pharma Engages HealthForce LLC for Sales, Marketing and Distribution of Designer Diagnostics' Test Kits
March 16, 2006
Nutra Pharma Announces Full-Day Workshop in India to Introduce Designer Diagnostics' Test Kits
February 28, 2006
The Wall Street Transcript Publishes Interview With Nutra Pharma CEO Rik J. Deitsch
February 22, 2006
Nutra Pharma Accepted Into the Stop TB Partnership
February 9, 2006
Nutra Pharma Reports Preclinical Results of RPI-78M in Multiple Sclerosis to Be Presented at Scientific Meeting
February 6, 2006
Nutra Pharma Names Microbiologist and Former Infectech Executive to Head the Advisory Board of Designer Diagnostics
January 26, 2006
Nutra Pharma Incorporates Designer Diagnostics, Inc. -- a New Subsidiary to Market Medical Test Kits
January 25, 2006
Nutra Pharma Acquires Patents and Licenses for Medical Test Kits
|
2005
December 27, 2005
Nutra Pharma Engages Isserman Consulting for Public Awareness and Investor Relations
December 20, 2005
Nutra Pharma Reports Final Results for ReceptoPharm's RPI-78M in Multiple Sclerosis Animal Model
December 19, 2005
Nutra Pharma Reports Discovery of New Gene Involved in Multiple Sclerosis
November 23, 2005
Nutra Pharma Penetrates the China Market
October 12, 2005
Nutra Pharma Announces ReceptoPharm Facilities Have Been GMP-Certified for Drug Production
September 16, 2005
Nutra Pharma Announces RPI-MN Shows Positive Effects against Drug-Resistant Strains of HIV
August 18, 2005
Nutra Pharma Announces $9.6 Million Financing Agreement
March 15, 2005
Interview with Nutra Pharma CEO Available Online
February 24, 2005
Wall Street Reporter Interviews Nutra Pharma's CEO
February 8, 2005
Business & Beyond to Feature Nutra Pharma Corporation
February 8, 2005
Nutra Pharma Reports that ReceptoPharm will be Presenting at The Adrenomyeloneuropathy (AMN) Forum in London
February 2, 2005
Nutra Pharma Corporation Will be Presenting at The Wall Street Analyst Forum
January 24, 2005
Nutra Pharma Names Dr. Tanvir Khandaker to Board of Directors
|
2004
December 8, 2004
Nutra Pharma Engages Research Group to Validate Portage BioMed Technology
December 7, 2004
Nutra Pharma Corrects November 9, 2004 Press Release Stating "Nutra Pharma Signs Agreement to Acquire Portage BioMed"
November 19, 2004
Nutra Pharma Reports Infectech Engages Lake Erie Research Institute for FDA Submissions
November 15, 2004
Nutra Pharma Reports Preliminary Results of ReceptoPharm's Multiple Sclerosis Drug in Microarray Studies
November 15, 2004
Nutra Pharma Names Dr. Stewart Lonky to Board of Directors
November 9, 2004
Nutra Pharma signs Agreement to Acquire Portage Biomed
November 3, 2004
Nutra Pharma Reports Further Validation of Infectech's Identikit Technology
October 5, 2004
Nutra Pharma Announces Board Changes and Loan Settlement
October 4, 2004
Nutra Pharma Reports Positive Results For ReceptoPharm's RPI-78M in Multiple Sclerosis Animal Model
September 29, 2004
Nutra Pharma Engages Equitilink LLC for Investor Relations
September 15, 2004
Nutra Pharma CEO Outlines Business Strategy on CEOcast.com
September 7, 2004
Nutra Pharma Reports Third Party Validation of Infectech's Identikit Technology
September 1, 2004
Nutra Pharma Reports ReceptoPharm Assays Prove That Experimental HIV Drug May Be Widely Available after Approval
August 30, 2004
Ohio State University Researcher Receives Competitive Grant Utilizing Infectech, Inc. Technology
August 2, 2004
Nutra Pharma Engages Research Group to Study RPI-78M in Multiple Sclerosis Assays
May 18, 2004
Nutra Pharma Reports ReceptoPharm's Completion of a Critical First Step in Their Lead Drug's Production
May 5, 2004
Nutra Pharma Reports Successful Completion of ReceptoPharm's HIV In-Vitro Studies at Two Leading Universities
April 28, 2004
Nutra Pharma Retains Rubenstein Investor Relations, Inc. as Investor Relations Consultants
|
|
|
|
| |
|
|
|
| |
|
| Click
Here for an Update on the Phase IIb Clinical Trial
Data. |
|
|
|
|
| |
|
|
|
|
